Ancora Advisors’s NEUROBIOLOGICAL TECHNOLOGS INC NTII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $0 | Hold |
85
| – | – | ﹤0.01% | 2456 |
|
|
2026
Q1 | $0 | Hold |
85
| – | – | ﹤0.01% | 2610 |
|
|
2025
Q4 | $0 | Hold |
85
| – | – | ﹤0.01% | 2556 |
|
|
2025
Q3 | $0 | Hold |
85
| – | – | ﹤0.01% | 2116 |
|
|
2025
Q2 | $0 | Hold |
85
| – | – | ﹤0.01% | 2100 |
|
|
2025
Q1 | $0 | Hold |
85
| – | – | ﹤0.01% | 1944 |
|
|
2024
Q4 | $0 | Hold |
85
| – | – | ﹤0.01% | 1954 |
|
|
2024
Q3 | $0 | Hold |
85
| – | – | ﹤0.01% | 1975 |
|
|
2024
Q2 | $0 | Sell |
85
-2,544,590
| -100% | – | ﹤0.01% | 1983 |
|
|
2024
Q1 | $0 | Hold |
2,544,675
| – | – | ﹤0.01% | 1918 |
|
|
2023
Q4 | $3 | Hold |
2,544,675
| – | – | ﹤0.01% | 1750 |
|
|
2023
Q3 | $2.54K | Hold |
2,544,675
| – | – | ﹤0.01% | 1468 |
|
|
2023
Q2 | $0 | Hold |
2,544,675
| – | – | ﹤0.01% | 2020 |
|
|
2023
Q1 | $3 | Hold |
2,544,675
| – | – | ﹤0.01% | 1946 |
|
|
2022
Q4 | $0 | Hold |
2,544,675
| – | – | ﹤0.01% | 2430 |
|
|
2022
Q3 | $0 | Hold |
2,544,675
| – | – | ﹤0.01% | 2502 |
|
|
2022
Q2 | $0 | Hold |
2,544,675
| – | – | ﹤0.01% | 2692 |
|
|
2022
Q1 | $0 | Hold |
2,544,675
| – | – | ﹤0.01% | 2848 |
|
|
2021
Q4 | $0 | Hold |
2,544,675
| – | – | ﹤0.01% | 2577 |
|
|
2021
Q3 | $1K | Hold |
2,544,675
| – | – | ﹤0.01% | 2195 |
|
|
2021
Q2 | $1K | Hold |
2,544,675
| – | – | ﹤0.01% | 1931 |
|
|
2021
Q1 | $13K | Hold |
2,544,675
| – | – | ﹤0.01% | 1404 |
|
|
2020
Q4 | $15K | Hold |
2,544,675
| – | – | ﹤0.01% | 1131 |
|
|
2020
Q3 | $10K | Hold |
2,544,675
| – | – | ﹤0.01% | 1151 |
|
|
2020
Q2 | $14K | Hold |
2,544,675
| – | – | ﹤0.01% | 1057 |
|
|
2020
Q1 | $13K | Hold |
2,544,675
| – | – | ﹤0.01% | 1138 |
|
|
2019
Q4 | $10K | Buy |
+2,544,675
| New | +$10K | ﹤0.01% | 1180 |
|
Ancora Advisors's NTII Position: Q2 2026 in Review
Ancora Advisors held its NEUROBIOLOGICAL TECHNOLOGS INC (NTII) position steady in Q2 2026 at 85 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2456.
Ancora Advisors first reported a position in NTII in Q4 2019 and has held it in 27 quarters since. The position peaked at $15K in Q4 2020. 1 fund tracked by Wall St. Rank holds NTII as of Q2 2026.
- Ancora Advisors held 85 shares of NEUROBIOLOGICAL TECHNOLOGS INC worth $0 as of Q2 2026.
- Ancora Advisors left its NEUROBIOLOGICAL TECHNOLOGS INC share count unchanged in Q2 2026.
- NEUROBIOLOGICAL TECHNOLOGS INC made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #2456 holding.
- Ancora Advisors first reported a position in NEUROBIOLOGICAL TECHNOLOGS INC in Q4 2019 and has held it in 27 quarters since.
- Ancora Advisors's NEUROBIOLOGICAL TECHNOLOGS INC position peaked at $15K in Q4 2020.
- 1 fund tracked by Wall St. Rank held NEUROBIOLOGICAL TECHNOLOGS INC as of Q2 2026.
Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.